Neurol. praxi. 2025;26(1):31-36 | DOI: 10.36290/neu.2024.070

Hereditary ataxias with onset after the age of 50

doc. MUDr. Martin Vyhnálek, Ph.D.1, MUDr. Emílie Vyhnálková, Ph.D.2, MUDr. Simona Karamazovová1, MUDr. Zuzana Blichová1, MUDr. Michaela Kuzmiak, Ph.D.1, MUDr. Jaroslava Paulasová-Schwabová, Ph.D.1
1 Centrum hereditárních ataxií, Neurologická klinika 2. lékařské fakulty Univerzity Karlovy a Fakultní nemocnice v Motole, Praha
2 Centrum hereditárních ataxií, Ústav biologie a lékařské genetiky 2. lékařské fakulty Univerzity Karlovy a Fakultní nemocnice v Motole, Praha

Chronic ataxias with onset after the age of 50 differ significantly from ataxias with childhood or early adulthood onset. This article focuses on late-onset hereditary ataxias, particularly on new subtypes such as CANVAS (Cerebellar Ataxia, Neuropathy, and Vestibular Areflexia Syndrome) and SCA27B (Spinocerebellar Ataxia type 27B). It describes their clinical manifestations and diagnostic methods, including genetic testing and differential diagnosis against other sporadic ataxias, such as Multiple system atrophy type C. We present the main principles of diagnosing hereditary ataxias and the diagnostic approach used at the Center of Hereditary Ataxias at the Motol University Hospital, which includes a combination of laboratory, imaging, and genetic tests that allow for the exclusion of acquired causes and a pragmatic diagnosis of hereditary diseases.

Keywords: hereditary ataxia, CANVAS, SCA27B, FXTAS, multiple system atrophy type C, genetic diagnostics, neurodegenerative diseases.

Received: October 28, 2024; Revised: October 28, 2024; Accepted: October 30, 2024; Prepublished online: October 30, 2024; Published: March 19, 2025  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Vyhnálek M, Vyhnálková E, Karamazovová S, Blichová Z, Kuzmiak M, Paulasová-Schwabová J. Hereditary ataxias with onset after the age of 50. Neurol. praxi. 2025;26(1):31-36. doi: 10.36290/neu.2024.070.
Download citation
PDF will be unlocked 19.3.2026

References

  1. Alvarez V, Arnold P, Kuntzer T. Very late-onset Friedreich ataxia: later than life expectancy? J Neurol. 2013;260(5):1408-1409. doi:10.1007/s00415-013-6874-6. Go to original source... Go to PubMed...
  2. Cabal-Herrera AM, Tassanakijpanich N, Salcedo-Arellano MJ, et al. Fragile X-Associated Tremor/Ataxia Syndrome (FXTAS): Pathophysiology and Clinical Implications. IJMS. 2020;21(12):4391. doi:10.3390/ijms21124391. Go to original source... Go to PubMed...
  3. Cortese A, Curro' R, Vegezzi E, et al. Cerebellar ataxia, neuropathy and vestibular areflexia syndrome (CANVAS): genetic and clinical aspects. Pract Neurol. 2022;22(1):14-18. doi:10.1136/practneurol-2020-002822. Go to original source... Go to PubMed...
  4. Cortese A, Simone R, Sullivan R, et al. Biallelic expansion of an intronic repeat in RFC1 is a common cause of late-onset ataxia. Nat Genet. 2019;51(4):649-658. doi:10.1038/s41588-019-0372-4. Go to original source... Go to PubMed...
  5. Cortese A, Tozza S, Yau WY, et al. Cerebellar ataxia, neuropathy, vestibular areflexia syndrome due to RFC1 repeat expansion. Brain. 2020;143(2):480-490. doi:10.1093/brain/awz418 Go to original source... Go to PubMed...
  6. Dade M, Berzero G, Izquierdo C, et al. Neurological Syndromes Associated with Anti-GAD Antibodies. IJMS. 2020;21(10):3701. doi:10.3390/ijms21103701. Go to original source... Go to PubMed...
  7. Danková M, Mušová Z, Jeřábek J, et al. CANVAS - nově identifikovaná genetická příčina ataxie s pozdním nástupem. Popis prvních diagnostikovaných pacientů v České republice. Cesk Slov Neurol N. 2021;84/117(4). doi:10.48095/cccsnn2021397. Go to original source...
  8. Fanciulli A, Wenning GK. Multiple-System Atrophy. Longo DL, ed. N Engl J Med. 2015;372(3):249-263. doi:10.1056/NEJMra1311488. Go to original source... Go to PubMed...
  9. Leehey MA, Berry-Kravis E, Min S, et al. Progression of tremor and ataxia in male carriers of the FMR1 premutation. Movement Disorders. 2007;22(2):203-206. doi:10.1002/mds.21252. Go to original source... Go to PubMed...
  10. Leehey MA. Fragile X-Associated Tremor/Ataxia Syndrome: Clinical Phenotype, Diagnosis, and Treatment. Journal of Investigative Medicine. 2009;57(8):830-836. doi:10.2310/JIM.0b013e3181af59c4. Go to original source... Go to PubMed...
  11. Migliaccio AA. Cerebellar ataxia with bilateral vestibulopathy: description of a syndrome and its characteristic clinical sign. Brain. 2004;127(2):280-293. doi:10.1093/brain/awh030. Go to original source... Go to PubMed...
  12. Pellerin D, Danzi MC, Renaud M, et al. Spinocerebellar ataxia 27B: A novel, frequent and potentially treatable ataxia. Clinical & Translational Med. 2024;14(1):e1504. doi:10.1002/ctm2.1504. Go to original source... Go to PubMed...
  13. Pellerin D, Danzi MC, Wilke C, et al. Deep Intronic FGF14 GAA Repeat Expansion in Late-Onset Cerebellar Ataxia. N Engl J Med. 2023;388(2):128-141. doi:10.1056/NEJMoa2207406. Go to original source... Go to PubMed...
  14. Rafehi H, Read J, Szmulewicz DJ, et al. An intronic GAA repeat expansion in FGF14 causes the autosomal-dominant adult-onset ataxia SCA27B/ATX-FGF14. The American Journal of Human Genetics. 2023;110(1):105-119. doi:10.1016/j.ajhg.2022.11.015. Go to original source... Go to PubMed...
  15. Rudaks LI, Yeow D, Ng K, Deveson IW, et al. An Update on the Adult-Onset Hereditary Cerebellar Ataxias: Novel Genetic Causes and New Diagnostic Approaches. Cerebellum. Published online May 18, 2024. doi:10.1007/s12311-024-01703-z. Go to original source... Go to PubMed...
  16. Szmulewicz DJ, Waterston JA, MacDougall HG, et al. Cerebellar ataxia, neuropathy, vestibular areflexia syndrome (CANVAS): a review of the clinical features and video-oculographic diagnosis. Annals of the New York Academy of Sciences. 2011;1233(1):139-147. doi:10.1111/j.1749-6632.2011.06158.x. Go to original source... Go to PubMed...
  17. Todd PK, Shakkottai VG. Overview of cerebellar ataxia in adults. Published online 2019.
  18. Vyhnálková E, Mušová Z, Zumrová A, et al. Dědičné cerebelární ataxie u dospělých. Neurol. praxi. 2019;20(5):344-350. doi:10.36290/neu.2019.139. Go to original source...
  19. Wenning GK, Stankovic I, Vignatelli L, et al. The Movement Disorder Society Criteria for the Diagnosis of Multiple System Atrophy. Movement Disorders. 2022;37(6):1131-1148. doi:10.1002/mds.29005. Go to original source... Go to PubMed...
  20. Wilke C, Pellerin D, Mengel D, et al. GAA- FGF14 ataxia (SCA27B): phenotypic profile, natural history progression and 4-aminopyridine treatment response. Brain. 2023;146(10):4144-4157. doi:10.1093/brain/awad157. Go to original source... Go to PubMed...
  21. Wood NW. Neurogenetics: A Guide for Clinicians. Cambridge University Press; 2012. Go to original source...




Neurology for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.